Additional Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Miami VA Healthcare System
    Miami FL. 33125
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Columbia University Medical Center-New York Presbyterian Hospital
    New York NY. 10024
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    University of Kansas Medical Center
    Kansas City KS. 66160
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Brigham and Women's Hospital
    Boston MA. 02115
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Northwestern University
    Chicago IL. 60611
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    NYU Langone Health
    New York NY. 10017
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    University of Pittsburgh Medical Center
    Pittsburgh PA. 15213
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    University of Alabama at Birmingham
    Birmingham AL. 35294
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Augusta University
    Augusta GA. 30912
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    University of Utah Health
    Salt Lake City UT. 84108
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    University of Kansas Medical Center
    Kansas City KS. 66160
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    Temple University Hospital
    Philadelphia PA. 19140
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    Keck School of Medicine at USC
    Los Angeles CA. 90033
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    Pulmonix, LLC
    Greensboro NC. 27403
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    National Jewish Health
    Denver CO. 80206
    View Details

  • A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

    Y & L Advance Health Care, Inc. d/b/a Elite Clinical Research
    Miami FL. 33144
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of Minnesota
    Minneapolis MN. 55455
    View Details